About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGPhase 3NCT06515184

Coenzyme Q10 for Gulf War Illness: A Replication Study

The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.

Lead sponsor: University of California, San Diego•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Janis B Ritchie, BSN

CONTACT

858-558-4950 jbritchie@ucsd.edu

Sponsors

Lead Sponsor

University of California, San Diego

Collaborators

United States Department of Defense

Age

50 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Does not have a disqualifying condition.
•Able to travel to a local Quest facility for study blood draws.
•Adequate internet access to allow ZoomPro visit participation and remote survey completion.
•Health prior to the Gulf War rated as "very good" or "excellent" (to exclude persons who may have had other health conditions with different mechanisms as the cause of their symptoms).
•Willing to defer initiation of discretionary treatments or supplements during the expected course of study participation.

Exclusion Criteria

•Participating in another clinical trial.
•Still-evolving adverse effects following another medication or health condition, such as covid or fluoroquinolone use.
•On Coumadin/ warfarin.
•Unable to participate for the required duration of the study.

Related studies

Cranial Electrotherapy Stimulation and Brain Imaging for Gulf War Syndrome

NCT07151248 · Gulf War Syndrome

RECRUITINGEARLY Phase 1

GWICTIC: NAC Mechanistic Study in Gulf War Veterans

NCT04987775 · Gulf War Syndrome

RECRUITINGPhase 3

Confirmation of Diet as a Treatment for Gulf War Illness

NCT05675878 · Gulf War Syndrome, Gulf War Illness

Not Yet RecruitingNA

Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness

NCT07266571 · Gulf War Syndrome

Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.

NCT03547869 · Gulf War Syndrome

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 1, 2026Terms

Trial snapshot

StatusRECRUITING

PhasePHASE3

Enrollment192

Start dateSep 2024

Last updatedMay 1, 2026

Condition

Gulf War Syndrome Persian Gulf Syndrome Mitochondrial Disorder, Respiratory Chain

Locations shown

UC San Diego

La Jolla, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions